CV Sciences (CVSI) Free Cash Flow (2011 - 2026)
CV Sciences (CVSI) posted Free Cash Flow of $98000.0 for Q1 2026, up 131.72% sequentially from -$309000.0 in Q4 2025, and up 180.99% YoY from $34876.5 in Q1 2025.
CV Sciences (CVSI) Free Cash Flow (2011 - 2026) Analysis & Trends
CV Sciences has reported Free Cash Flow for 16 years, with the latest figure at $98000.0 in Q1 2026.
- Quarterly Free Cash Flow rose 180.99% year-over-year to $98000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$290000.0 (up 39.83% YoY) and the FY2025 annual result came in at -$509000.0, up 42.09% from the prior year.
- Free Cash Flow grew to $98000.0 in Q1 2026 per CVSI's latest filing, from -$309000.0 in the prior quarter.
- Over five years, Free Cash Flow peaked at $1.4 million in Q2 2023 and troughed at -$1.2 million in Q2 2022.
- A 5-year average of -$54235.3 and a median of -$121000.0 in 2025 frame the typical range for Free Cash Flow.
- The sharpest annual moves came in 2024 and 2025: Free Cash Flow sank 542.11% in 2024, then jumped 517.54% in 2025.
- Over 5 years, Free Cash Flow stood at $210000.0 in 2022, then plunged by 154.29% to -$114000.0 in 2023, then sank by 59.65% to -$182000.0 in 2024, then sank by 69.78% to -$309000.0 in 2025, then jumped by 131.72% to $98000.0 in 2026.
- According to Business Quant data, Free Cash Flow over the past three periods registered $98000.0, -$309000.0, and -$317000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 307.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 538.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 1.14 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 205.60 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 329.00 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 128.60 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 244.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | CV Sciences | 3.90 Mn | 3.63 Mn | 1.45 Mn | 13,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13,000.00 |
| Jun 30, 2026 | 13,000.00 |
| Mar 31, 2026 | 98,000.00 |
| Mar 31, 2026 | 98,000.00 |
| Dec 31, 2025 | -309,000.00 |
| Dec 31, 2025 | -309,000.00 |
| Sep 30, 2025 | -317,000.00 |
| Sep 30, 2025 | -317,000.00 |
| Jun 30, 2025 | 238,000.00 |
| Jun 30, 2025 | 238,000.00 |
| Mar 31, 2025 | -121,000.00 |
| Mar 31, 2025 | -121,000.00 |
| Dec 31, 2024 | -182,000.00 |
| Dec 31, 2024 | -182,000.00 |
| Sep 30, 2024 | -122,000.00 |
| Sep 30, 2024 | -122,000.00 |
| Jun 30, 2024 | -57,000.00 |
| Jun 30, 2024 | -57,000.00 |
| Mar 31, 2024 | -518,000.00 |
| Mar 31, 2024 | -518,000.00 |